ADAMAS PHARMACEUTICALS INC's ticker is ADMS and the CUSIP is 00548A106.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $7,169,000 | -18.7% | 1,460,000 | -12.6% | 1.34% | -8.6% |
| Q2 2021 | $8,821,000 | +10.0% | 1,670,600 | 0.0% | 1.46% | +24.4% |
| Q1 2021 | $8,019,000 | +24.5% | 1,670,600 | +12.3% | 1.18% | +40.1% |
| Q4 2020 | $6,442,000 | +5.1% | 1,487,800 | 0.0% | 0.84% | -29.9% |
| Q3 2020 | $6,130,000 | +149.4% | 1,487,800 | +55.0% | 1.20% | +141.7% |
| Q2 2020 | $2,458,000 | -51.5% | 960,000 | +231.0% | 0.50% | -76.6% |
| Q2 2017 | $5,072,000 | -0.1% | 290,000 | 0.0% | 2.12% | -16.1% |
| Q1 2017 | $5,075,000 | +5.4% | 290,000 | +1.8% | 2.53% | -11.0% |
| Q4 2016 | $4,817,000 | +17.4% | 285,000 | +14.0% | 2.84% | +32.2% |
| Q3 2016 | $4,103,000 | -9.7% | 250,000 | -16.7% | 2.15% | -29.2% |
| Q2 2016 | $4,542,000 | -25.1% | 300,000 | -6.2% | 3.03% | -19.8% |
| Q1 2016 | $6,064,000 | +12.7% | 320,000 | +68.4% | 3.78% | +68.1% |
| Q4 2015 | $5,380,000 | +93.9% | 190,000 | +14.7% | 2.25% | +64.8% |
| Q3 2015 | $2,774,000 | -29.5% | 165,700 | +10.5% | 1.36% | -12.8% |
| Q2 2015 | $3,933,000 | -11.8% | 150,000 | -41.2% | 1.56% | -24.4% |
| Q1 2015 | $4,460,000 | – | 255,000 | – | 2.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Stonepine Capital Management, LLC | 808,431 | $3,501,000 | 2.68% |
| AIGH Capital Management LLC | 875,851 | $3,793,000 | 1.54% |
| Healthcare Value Capital, LLC | 100,000 | $433,000 | 1.46% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 440,955 | $1,909,000 | 1.11% |
| Opaleye Management Inc. | 1,487,800 | $6,442,000 | 0.84% |
| Worth Venture Partners, LLC | 225,106 | $975,000 | 0.77% |
| ARMISTICE CAPITAL, LLC | 2,742,000 | $11,873,000 | 0.40% |
| DELTEC ASSET MANAGEMENT LLC | 245,399 | $1,063,000 | 0.16% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 278,011 | $1,204,000 | 0.15% |
| Mosaic Family Wealth, LLC | 91,807 | $398,000 | 0.13% |